Medical Research
A personalized heart ablation strategy substantially improved rhythm control in selected patients with persistent atrial fibrillation, according to a randomized clinical trial published August 30, 2026, in JAMA. The …
An experimental biologic produced substantial improvements in adults with moderate-to-severe atopic dermatitis in a randomized phase 2b trial published in The Lancet. The drug, rezpegaldesleukin, works differently from many newer eczema …
A blood test analyzing how DNA fragments are packaged in the bloodstream distinguished recurrent or metastatic breast cancer from primary disease in a 2026 study, suggesting that the physical …
Key Takeaways: Medical breakthroughs start in research labs and require years of testing before reaching the public. Clinical trials follow a strict, multi-phase process to ensure treatments are safe …
Key Takeaways: External control arms use real-world or historical data to replace placebo groups in trials. They speed up research and reduce ethical concerns, especially in rare diseases. Regulators …
Key Takeaways: Advanced analytics is making clinical trials more personalized, efficient, and inclusive. Bayesian and adaptive trial designs allow flexible adjustments based on real-time data. Patient recruitment and retention …
A Current Biology study showed that restoring mu opioid receptor signaling in a small brainstem region normalized nerve-injury-induced hypersensitivity in mice. The finding identifies a potentially valuable drug target—but …
Key Takeaways Researchers have identified caspase-1, an inflammatory enzyme involved in activating interleukin-1β (IL-1β), as a potential target for intercepting lung cancer during its early development. In a genetically …
A personalized mRNA cancer vaccine has succeeded in a Phase 3 melanoma trial, but that does not mean researchers have developed a vaccine that prevents melanoma—or that all of …
Two Phase 3 trials involving 1,399 adults and adolescents found substantial scalp, eyebrow, and eyelash regrowth with upadacitinib after 24 weeks. The results are promising, but long-term safety, durability, …
